[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"organisation-e5d796ee-3253-4d8b-b9ea-04e65fdb5025":3,"organisation-articles-e5d796ee-3253-4d8b-b9ea-04e65fdb5025":9},{"id":4,"title":5,"color":6,"path":7,"logoUrl":8},"e5d796ee-3253-4d8b-b9ea-04e65fdb5025","Solo Partners B.V.","#072A38;","solopartners","https:\u002F\u002Forder.perssupport.nl\u002Ffile\u002Flogos\u002Fe5d796ee-3253-4d8b-b9ea-04e65fdb5025\u002Ff514f2c6-affa-495e-91b4-002e550a7dc6.jpg",[10,21],{"id":11,"title":12,"pubDate":13,"logoUrl":14,"thirdParty":15,"orgId":4,"branches":16,"description":20},"0c33230c-6602-4bb0-b140-00085bcdc18f","Zzp’ers in de zorg niet duurder dan medewerkers in loondienst","2022-02-17T10:39:05.774+01:00","https:\u002F\u002Fwww.persberichten.nl\u002Ffile\u002Flogos\u002Fe5d796ee-3253-4d8b-b9ea-04e65fdb5025\u002Fb75f4d92-325a-489f-8f43-cff16ee45776.jpg",false,[17],{"id":18,"title":19},"29100","Zorg","Zzp’ers in de zorg zijn niet duurder dan medewerkers in loondienst. SoloPartners, de brancheorganisaties voor zzp’ers in de zorg vind de conclusie die het progr",{"id":22,"title":23,"pubDate":24,"logoUrl":25,"thirdParty":15,"imageUrls":26,"orgId":4,"branches":28,"description":124},"0f0a2e06-6a2b-438e-aa92-947d5fa08592","PGB-zorgverleners ontvangen vaccinatie-uitnodiging","2021-03-24T09:22:00.387+01:00","https:\u002F\u002Fwww.persberichten.nl\u002Ffile\u002Flogos\u002Fe5d796ee-3253-4d8b-b9ea-04e65fdb5025\u002Ff514f2c6-affa-495e-91b4-002e550a7dc6.jpg",[27],"https:\u002F\u002Flh3.googleusercontent.com\u002FdgeKXqJk4j9AKupi8gCHELkLGY3pheCMzOL6Ujd9Elj0vHqSMKwH0oF2bRci7pa5w4JskD1RkfLcllmTgKy-11WOnGvlE5V4wQ",[29,32,35,38,41,44,47,50,53,56,58,61,64,67,70,73,76,79,82,85,89,93,96,99,102,105,108,111,115,118,121],{"id":30,"title":31,"parentId":18},"29183","Medisch specialisme",{"id":33,"title":34,"parentId":18},"29127","Aflevering van geneesmiddelen",{"id":36,"title":37,"parentId":18},"29118","Gezondheidszorg",{"id":39,"title":40,"parentId":18},"29130","Epidemiologie",{"id":42,"title":43,"parentId":18},"29159","Geneeskunde",{"id":45,"title":46,"parentId":18},"29179","Geneesmiddelen op voorschrift",{"id":48,"title":49,"parentId":18},"29141","Gezondheid",{"id":51,"title":52,"parentId":18},"29200","Gezondheidsbeheer",{"id":54,"title":55,"parentId":18},"93782","Gezondheidsbeleid",{"id":57,"title":37,"parentId":18},"29143",{"id":59,"title":60,"parentId":18},"29138","Mantelzorg",{"id":62,"title":63,"parentId":18},"29149","Immunologie",{"id":65,"title":66,"parentId":18},"29151","Intensive care",{"id":68,"title":69,"parentId":18},"29157","Medische producten en diensten",{"id":71,"title":72,"parentId":18},"29158","Medische technologie",{"id":74,"title":75,"parentId":18},"29156","Medische-praktijkbeheer",{"id":77,"title":78,"parentId":18},"29165","Toepassingen voor nieuwe geneesmiddelen",{"id":80,"title":81,"parentId":18},"29146","Ziekenhuisartsen",{"id":83,"title":84,"parentId":18},"29147","Ziekenhuizen",{"id":86,"title":87,"parentId":88},"34134","Sociale zaken","28100",{"id":90,"title":91,"parentId":92},"34130","Senioren","34119",{"id":94,"title":95,"parentId":88},"28127","Nationale overheid",{"id":97,"title":98,"parentId":88},"28133","Overheidsdiensten",{"id":100,"title":101,"parentId":88},"28134","Overheidsdiensten - andere",{"id":103,"title":104,"parentId":88},"28111","Politieke partijen",{"id":106,"title":107,"parentId":88},"28126","Regionale overheid",{"id":109,"title":110,"parentId":88},"41103","Actualiteiten",{"id":112,"title":113,"parentId":114},"47119","Laboratoriumgeneeskunde en -uitrusting","47100",{"id":116,"title":117,"parentId":114},"94892","Onderzoek en ontwikkeling",{"id":119,"title":120,"parentId":114},"47139","Wetenschap",{"id":122,"title":123,"parentId":114},"47140","Wetenschap - andere","De volgende groep zorgverleners in de vaccinatiestrategie van het RIVM [1] is aan de beurt, namelijk de PGB-zorgverleners. Verschillende zorgverleners ontvangen"]